Aquestive Therapeutics, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:AQST) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 102.23 M93.7 M163.56 M160.43 M141.13 M Total liabilities 163.16 M166.29 M167.67 M194.09 M175.18 M Total equity -60.93 M-72.59 M-4.11 M-33.66 M-34.05 M Total liabilities & shareholders' equities 102.23 M93.7 M163.56 M160.43 M141.13 M Total debt ————— Net debt —————

News

Aquestive Therapeutics (AQST) Moves 6.6% Higher: Will This Strength Last?

Aquestive Therapeutics: Rating Downgrade Despite Probability Of Anaphylm Approval

Xeris Looks Ridiculously Cheap If Growth Forecasts Are Even Halfway Right (NASDAQ:XERS)

Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics

Aquestive Therapeutics (AQST) Reports Q1 Loss, Beats Revenue Estimates

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Beats Revenue Estimates

Will Journey Medical Corporation (DERM) Report Negative Q1 Earnings? What You Should Know

Will Aquestive Therapeutics (AQST) Report Negative Q1 Earnings? What You Should Know

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Aquestive Therapeutics: Post-CRL Risk, Timeline, And Valuation (NASDAQ:AQST)

Aquestive Therapeutics chief people officer Boyd sells $124k in stock

Aquestive Therapeutics CEO Barber sells $753,965 in stock